Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: J Autism Dev Disord. 2022 Jan 4;52(12):5308–5320. doi: 10.1007/s10803-021-05377-y

Table 4.

ASD clinician review interrater reliability by site, sex and race/ethnicity, cognitive level, and ASD classification, ADDM network surveillance year 2014

ADDM 2014
(n = 924 pairs;
34 reviewers)
% Agree Kappa
ADDM network site*
 Arkansas .97 .93
 Arizona .89 .78
 Colorado .91 .81
 Georgia .91 .82
 Maryland .89 .77
 Minnesota .87 .75
 Missouri .92 .82
 North Carolina .96 .92
 New Jersey .92 .84
 Tennessee .89 .75
 Wisconsin .93 .86
Sex
 Male (N = 710) .92 .83
 Female (N = 214) .95 .90
Race/ethnicity*
 White, Non-Hispanic (N = 433) .93 .85
 Black, Non-Hispanic (N = 249) .92 .85
 Asian or Pacific Islander, Non-Hispanic (N = 39) .90 .80
 Other Race or Multiracial, Non-Hispanic (N = 28) .93 .86
 Race Missing/Not Stated, Non-Hispanic (N = 16) .91 1.0
 Hispanic (N = 155) 1.00 .82
Cognitive level from most recent test in records
 Intellectually disabled (IQ < = 70) (N = 211) .92 .81
 Borderline (IQ 71–85) (N = 160) .92 .83
 Average or above average (IQ > = 85) (N = 315) .91 .83
 No cognitive test data (N = 238) .95 .89
ASD classification from source records
 ASD diagnosis or eligibility on record (N = 430) .97 .77
 ASD suspected, but no documented diagnosis or eligibility on record (N = 199) .85 .70
 No mention of ASD on record (N = 295) .90 .68